• Immunofluorescence analysis of HUVEC cells, using ZNF174 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from HeLa cells, using ZNF174 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using AW-1 Polyclonal Antibody

Anti-ZNF174 antibody (201-250 aa) (STJ91790)

SKU:
STJ91790

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Zinc finger protein 174 (201-250 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ZNF174
Gene ID: 7727
Uniprot ID: ZN174_HUMAN
Immunogen Region: 201-250 aa
Specificity: AW-1 Polyclonal Antibody detects endogenous levels of AW-1 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human ZNF174 at the amino acid range 201-250
Function Transcriptional repressor.
Protein Name Zinc Finger Protein 174
Aw-1
Zinc Finger And Scan Domain-Containing Protein 8
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Zinc Finger Protein 174 antibody
Anti-Aw-1 antibody
Anti-Zinc Finger And Scan Domain-Containing Protein 8 antibody
Anti-ZNF174 antibody
Anti-ZSCAN8 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance